• About Us
  • Business Areas
  • R & D
  • Manufacturing
  • Beyond Business
  • Investors
  • Careers
  • Contact Us

Investors

Investors > FY 2011-12

    • Overview
    • Chairman's Statement
    • Shareholder Information
    • Policies or Statutory Documents
    • IEPF
    • Debentures
    • Amalgamation
    • MOA/AOA
    • Procedure for Dematerialisation of Shares
    • Archives
    • Credit Ratings
    • CSR
    • AGM Transcript
    • Annual Return
    • Disclosures under Regulation 46 and 62 of SEBI LODR
  • Financial
    • 2022-23
    • 2021-22
    • 2020-21
    • 2019-20
    • 2018-19
    • 2017-18
    • 2016-17
    • 2015-16
    • 2014-15
    • 2013-14
    • 2012-13
    • 2011-12

Investors > FY 2011-12



1. Annual Report

Annual Report

2. Intimation to Stock Exchange

Quarterly Compliance Report Q2
Quarterly Compliance Report Q1

3. Quarterly Results

  • Q1 11-12
  • Q2 11-12
  • Q3 11-12
  • Q4 11-12
Investors Conference Call Transcripts
Stand Alone Results
Consolidated Results
Investors Conference Call Transcripts
Stand Alone Results
Consolidated Results
Press Release 21% revenue growth in Q3 FY12
Investors Conference Call Transcripts
Stand Alone Results
Consolidated Results
Press Release on Q4 Results
Investors Conference Call Transcripts
Stand Alone Results
Consolidated Results

Details of Nodal Officer

Name : Chintan Trivedi

Designation : Company Secretary

E-mail Id : investorservices@torrentpharma.com

IEPF Authority - Refund web page

IEPF Authority - Refund web page >>

Torrent Pharmaceuticals Ltd. © Copyright 2017
Privacy Policy | Disclaimer | Site Map